Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 70

Understand CYP1A2 genetic test results for caffeine and clozapine, including why smoking, inflammation, interactions, and drug levels often matter more.

CYP1A2 Genetic Test: Caffeine, Clozapine, Drug Metabolism, and Results

Understand CYP2B6 test results for efavirenz, methadone, and bupropion, including metabolizer phenotypes, drug-specific guidance, and test limitations.

CYP2B6 Genetic Test: Efavirenz, Methadone, Bupropion, and Results

Learn how CYP2C9 test results affect warfarin, NSAIDs, and phenytoin, including metabolizer types, dose guidance, allele coverage, monitoring, and safety limits.

CYP2C9 Genetic Test: Warfarin, NSAIDs, Phenytoin, and Results

Understand CYP2C19 clopidogrel test results, loss-of-function alleles, Plavix response, alternatives after PCI, and cardiovascular risk implications.

CYP2C19 Clopidogrel Genetic Test: Plavix Response, Heart Risk, and Results

Understand CYP2C19 test results for clopidogrel, antidepressants, and PPIs, including metabolizer types, dosing implications, interactions, and limitations.

CYP2C19 Genetic Test: Clopidogrel, Antidepressants, PPIs, and Results

Understand CYP2D6 and CYP2C19 antidepressant test results, SSRI dosing implications, poor and rapid metabolizer findings, interactions, limits, and follow-up.

CYP2D6 and CYP2C19 Antidepressant Pharmacogenetic Test: SSRI Response and Results

Understand CYP2D6 genetic test results, poor and ultrarapid metabolizer meanings, copy-number issues, drug effects, phenoconversion, and safe clinical use.

CYP2D6 Genetic Test: Drug Metabolism, Poor Metabolizer, and Results

Understand CYP2D6 opioid test results for codeine, tramadol, and oxycodone, including poor and ultrarapid metabolism, interactions, safety, and limits.

CYP2D6 Opioid Pharmacogenetic Test: Codeine, Tramadol, Oxycodone, and Results

Learn what a CYP3A4 genetic test shows, how CYP3A4*22 affects drug metabolism, which medicines may be influenced, and how to interpret results safely.

CYP3A4 Genetic Test: Drug Metabolism, Variants, and Results

Understand CYP3A5 genetic test results, tacrolimus expresser status, genotype-guided starting doses, trough monitoring, and safe transplant medication use.

CYP3A5 Genetic Test: Tacrolimus Dosing, Metabolism, and Results

Learn how DPYD genetic test results, activity scores, and DPD deficiency affect 5-FU and capecitabine dosing, toxicity risk, monitoring, and urgent care.

DPYD Genetic Test: Fluoropyrimidine Toxicity, 5-FU, Capecitabine, and Results

Learn how fluoropyrimidine pharmacogenetic testing uses DPYD results to guide 5-FU and capecitabine starting doses, monitoring, toxicity prevention, and emergency care.

Fluoropyrimidine Pharmacogenetic Test: DPYD, 5-FU, Capecitabine Toxicity, and Results

Understand G6PD genetic testing, enzyme activity, medication hemolysis risk, result interpretation, test limitations, and safe next steps.

G6PD Genetic Test: Medication Hemolysis Risk, Deficiency, and Results

Learn how HLA-A*31:01 testing estimates carbamazepine hypersensitivity risk, how positive and negative results guide prescribing, and which symptoms need urgent care.

HLA-A*31:01 Genetic Test: Carbamazepine Hypersensitivity Risk and Results

Understand HLA-B*15:02 testing for carbamazepine skin reaction risk, result interpretation, ancestry-based screening, related-drug choices, and urgent SJS/TEN warning signs.

HLA-B*15:02 Genetic Test: Carbamazepine Skin Reaction Risk and Results

Understand HLA-B*57:01 testing before abacavir, positive and negative result meaning, hypersensitivity symptoms, permanent rechallenge precautions, and HIV treatment alternatives.

HLA-B*57:01 Genetic Test: Abacavir Hypersensitivity Risk and Results

1...697071...137 Page 70 of 137